tirzepatide liver Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic disease (MASLD) Tirzepatide enhances liver structural integrity

Vitamin and nutrient infusions described on this site are offered as wellness services intended to complement, not replace, a healthy lifestyle and routine medical care

Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects...

Novo Nordisk announced FDA approval of once-daily oral Wegovy pill (semaglutide) tablets 25 mg for adults with obesity, or adults with overweight who also have...

The only live Akkermansia probiotic clinically shown to fortify the gut lining, reduce gut permeability, and support gut health

A common simple protocol used in laboratory studies starts with 0.5 mg of Tirzepatide once per week, administered subcutaneously. The dose is then titrated upward by 0.51 mg every 4 weeks until the individual researcher reaches a comfortable maintenance level. Maintenance dosing is subjective and based on personal response and tolerance